Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth

Australian Dental Journal

Volumn 52, Issue 4, 2007, Pages 295-299

  Güncü, Güliz N ^a   Caglayan F ^a   Dincel A ^a   Bozkurt, A ^a   Ozmen F ^a   Karabulut, E ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Gingival crevicular fluid; HPLC; Nifedipine induced gingival overgrowth; Risk factors

Indexed keywords

NIFEDIPINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; EPIDEMIOLOGY; FEMALE; GINGIVA OVERGROWTH; GINGIVITIS; HUMAN; MALE; MIDDLE AGED; TOOTH PLAQUE;

ADULT; AGED; DENTAL PLAQUE; EPIDEMIOLOGIC METHODS; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVAL OVERGROWTH; HUMANS; MALE; MIDDLE AGED; NIFEDIPINE; VASODILATOR AGENTS;

EID: 38349083426     PISSN: 00450421     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1834-7819.2007.tb00505.x     Document Type: Article

References (30)

1. Seymour RA, Heasman PA. Drugs and the periodontium. J Clin Periodontol 1988;15:1-16.
2. Barclay S, Thomsan JM, Idle JR, Seymour RA. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;19:311-314.
3. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996;23:165-175.
4. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000;27:217-223.
5. Dannewitz B, Edrich C, Tomakidi P, et al. Elevated levels of gene expression for collagen and decorin in human gingival overgrowth. J Clin Periodontol 2006;33:510-516.
6. Flynn JC, Henderson JS, Johnson RB. Synergism between nifedipine and cyclosporine A on the incorporation of [35S] sulfate into human gingival fibroblast cultures in vitro. J Periodont Res 2006;41:316-321.
7. McGaw T, Lam S, Coates J. Cyclosporine induced gingival overgrowth. Correlation with dental plaque scores, gingivitis scores, and cyclosporine levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
8. Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M, Laher MH. Factors influencing phenytoin-induced gingival enlargement. J Clin Periodontol 2000;27:506-512.
9. Uitto VJ. Gingival crevice fluid - an introduction. Periodontology 2000 2003;31:9-11.
10. Ellis JS, Seymour RA, Monkman SC, Idle JR. Disposition of nifedipine in plasma and gingival crevicular fluid in relation to drug-induced gingival overgrowth. J Periodont Res 1993;28:373-378.
11. Ellis JS, Seymour RA, Thomason JM. Amlodipine induced gingival overgrowth and sequestration in crevicular fluid. Lancet 1993;341:1102-1103.
12. McLaughlin WS, Ball DE, Seymour RA, Kamali F, White K. The pharmacokinetics of fenitoin in gingival crevicular fluid and plasma in relation to gingival overgrowth. J Clin Periodontol 1995;22:942-945.
13. Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A. Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 2000;27:53-60.
14. Tozum TF, Yildirim A, Caglayan F, Dincel A, Bozkurt A. Serum and gingival crevicular fluid levels of ciprofloxacin in patients with periodontitis. J Am Dent Assoc 2004;135:1728-1732.
15. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
16. Miller CS, Damm DD. Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992;63:453-456.
17. Miranda J, Brunet L, Roset P, Berrini L, Farre M, Mendieta C. Prevalence and risk of gingival enlargement in patients treated with nifedipine. J Periodontol 2001;72:605-611.
18. Thomason JM, Ellis JS, Jovanovski V, Corson M, Lynch E, Seymour RA. Analysis of changes in gingival contour from three-dimensional co-ordinate data in subjects with drug-induced gingival overgrowth. J Clin Periodontol 2005;32:1069-1075.
19. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporine-induced gingival changes. J Clin Periodontol 1991;18:107-110.
20. Löe H. The gingival index, the plaque index and retention index systems. J Clin Periodontol 1967;38:61-70.
21. Nowicki D, Vogel RI, Melcer S, Deasy MJ. The gingival bleeding time index. J Periodontol 1981;42:260-262.
22. Rudin HJ, Overdiek HF, Rateitschak KH. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta 1970;14:21-26.
23. Deinzer R, Mossanen BS, Herforth A. Methodological considerations in the assessment of gingival crevicular fluid volume. J Clin Periodontol 2000;27:481-488.
24. Soons PA, Schellens JHM, Roosemalen MCM, Breimer DD. Analysis of nifedipine and its pyridine metabolite dehydronifedipine in blood and plasma: review and improved high-performance liquid chromatography. J Pharm Biomed Anal 1991;9:475-484.
25. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of gingival overgrowth induced by calcium channel blockers: a community-based study. J Periodontol 1999;70:63-67.
26. Aimetti M, Romano F, Debernardi C. Effectiveness of periodontal therapy on the severity of cyclosporine A-induced gingival overgrowth. J Clin Periodontol 2005;32:846-850.
27. Rivera-Hidalgo F. Smoking and periodontal disease. Periodontology 2000 2000;32:50-58.
28. Persson L, Bergstrom J, Gustafsson A, Asman B. Tobacco smoking and gingival neutrophil activity in young adults. J Clin Periodontol 1999;26:9-13.
29. Uzel MI, Kantarci A, Hong H, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001;72:921-931.
30. Sakagami G, Sato E, Sugita Y, et al. Effects of nifedipine and interleukin-1 on the expression of collagen, matrix metalloproteinase-1, and tissue inhibitor of metalloproteinase-1 in human gingival fibroblasts. J Periodont Res 2006;41:266-272.